Jump to content

Respiratory disease specialist objects to BMA plan to administer Favipiravir to all COVID-19 patients


snoop1130

Recommended Posts

S__10567690.jpg

 

The president of the Thoracic Society of Thailand, and head of the Department of Respiratory Diseases and Tuberculosis at Mahidol University, Dr. Nitipat Jiarakul, has voiced disagreement with the Bangkok Metropolitan Administration’s (BMA) plan to administer the Favipiravir anti-viral drug to all COVID-19 patients in field hospitals.

 

In his Facebook post today (Tuesday), Dr. Nitipat said that Favipiravir is registered in Thailand’s list of approved drugs and was approved for use in COVID-19 patients suffering from serious lung infections, as a special case, to prevent the spread of the disease during the first wave of COVID-19 pandemic, which was in short supply.

 

He said the working committee, tasked with supervising the use of the drug, then believed that the drug would reduce the severity of the symptoms induced by COVID-19 and could save lives, although the drug, which is manufactured in Japan, was not used in the West and, hence, there are is no scientific evidence of its efficacy in treating COVID-19.

 

Full Story: https://www.thaipbsworld.com/respiratory-disease-specialist-objects-to-bma-plan-to-administer-favipiravir-to-all-covid-19-patients/

 

Logo-top-.png

-- © Copyright Thai PBS 2021-05-04
 
  • Like 1
Link to comment
Share on other sites

19 minutes ago, from the home of CC said:

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467067/  - the insert below comes from this source

 

Favipiravir was first used against SARS-CoV-2 in Wuhan at the very epicenter of the pandemic. Then, as the pandemic spread to Europe, this drug received approval for emergency use in Italy, and currently has been in use in Japan, Russia, Ukraine, Uzbekistan, Moldova, and Kazakhstan. Approval has also recently been granted in Saudi Arabia and the UAE. Thereafter, Turkey, Bangladesh, and most recently Egypt have also seen recent commercial launches. In June 2020, favipiravir received the DCGI approval in India for mild and moderate COVID-19 infections

 

this Dr. imo needs to catch up on his reading. I have no idea whether it's efficacious or not but there is evidence from many sources..

I think the doctor knows more than you do, old boy. The article you post is 8 months out of date and the drug has since been proven to be completely useless. There are better treatment options available.

  • Like 2
Link to comment
Share on other sites

24 minutes ago, edwardandtubs said:

the drug has since been proven to be completely useless.

 

That's what I heard as well. Something else to consider is - what are the side effects of this drug?

 

Link to comment
Share on other sites

And how serious is all this? In my country, in the beginning, the AstraZeneca vaccine was not allowed for people over 65 and the second jab given 3 to 4 weeks later. A month and an half later, the same Astrazeneca is given to people older than 65 by priority, with the second jab given about 3 months later. . .  Rigorous science.

 

I took the jab reluctantly, hoping to return "soon" to my wife in Thailand . . .

  • Like 1
Link to comment
Share on other sites

1 hour ago, edwardandtubs said:

I think the doctor knows more than you do, old boy. The article you post is 8 months out of date and the drug has since been proven to be completely useless. There are better treatment options available.

There have only been very little research done to date on Favipiravir and it’s effect on Covid in humans. Here is one small study showing a positive effect; https://link.springer.com/article/10.1007/s00705-021-04956-9

 

In the UK they have just started a large trial into Favipiravir. 
https://www.nihr.ac.uk/news/favipiravir-to-be-investigated-as-a-possible-covid-19-treatment-for-at-home-recovery-in-the-principle-trial/27426

 

The decision to add favipiravir to the trial was made by the University of Oxford researchers and trial steering committee leading the trial in conjunction with the Chief Medical Officer, following a recommendation by the UK COVID-19 Therapeutics Advisory Panel.”

 

Link to comment
Share on other sites

but Anutin the builder and highly qualified health professional knows better 

 

 

better listen to him or you might face some attitude adjustment 

 

His lack of knowledge on the health of the nation is measured on how much money he has and how much he continues to make, his money makes him an expert - not 

 

I believe that the thai people are rising to this BS and pretty soon they will all be held to account 

 

They might be feeling very comfortable right now in the power base that they think they have, I have a feeling that the Thai people have had enough

Link to comment
Share on other sites

8 hours ago, Walkabout said:

I took the jab reluctantly, hoping to return "soon" to my wife in Thailand . . .

Me too, 13 months now, but I'm getting the feeling Thailand will have landed on the moon with a successful space program before a full vaccine roll out and i can get back to her

Edited by RichardColeman
  • Like 1
Link to comment
Share on other sites

8 hours ago, smedly said:

but Anutin the builder and highly qualified health professional knows better 

 

 

better listen to him or you might face some attitude adjustment 

 

His lack of knowledge on the health of the nation is measured on how much money he has and how much he continues to make, his money makes him an expert - not 

 

I believe that the thai people are rising to this BS and pretty soon they will all be held to account 

 

They might be feeling very comfortable right now in the power base that they think they have, I have a feeling that the Thai people have had enough

There will be no national vote for a very long time to come, Prayut will make sure all this is long gone before another rigging session.

Link to comment
Share on other sites

16 hours ago, edwardandtubs said:

I think the doctor knows more than you do, old boy. The article you post is 8 months out of date and the drug has since been proven to be completely useless. There are better treatment options available.

 

Seems its not done and dusted yet, someone thinks its worth a bash! This one less than a month old.

 

https://www.nihr.ac.uk/news/favipiravir-to-be-investigated-as-a-possible-covid-19-treatment-for-at-home-recovery-in-the-principle-trial/27426

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.




  • Popular Now

×
×
  • Create New...